BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

7.975 -0.125 (-1.54%)

Delayed Quote Updated: 3:26 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday ↗

May 06, 2024

A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.

Via The Motley Fool

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance ↗

May 06, 2024

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by Orladeyo revenue growth. With strong patient demand and strategic...

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript ↗

May 06, 2024

BCRX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session ↗

May 06, 2024

Via Benzinga

BCRX Stock Earnings: BioCryst Pharma Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

BCRX stock results show that BioCryst Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

A Preview Of BioCryst Pharma's Earnings ↗

February 23, 2024

Via Benzinga

What's Going On With BioCryst Pharmaceuticals Stock? ↗

January 08, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday.

Via Benzinga

Where BioCryst Pharma Stands With Analysts ↗

November 20, 2023

Via Benzinga

Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects ↗

March 01, 2024

These penny stocks offer triple digit returns to investors right now but not many investors are aware of them.

Via InvestorPlace

BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript ↗

February 26, 2024

BCRX earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

What's Going On With BioCryst Stock After Earnings? ↗

February 26, 2024

BioCryst reported quarterly losses of 28 cents per share, missing the analyst consensus estimate of losses of 24 cents by 16.67% and representing a 26.32% increase over losses of 38 cents per share...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 26, 2024

Via Benzinga

Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

February 26, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by over 50 points on Monday.

Via Benzinga

Topics Stocks

What 7 Analyst Ratings Have To Say About BioCryst Pharma ↗

September 25, 2023

Via Benzinga

Analyst Expectations for BioCryst Pharma's Future ↗

May 04, 2023

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Soaring Today ↗

May 03, 2023

The biotech's Q1 earnings report contained a number of positives.

Via The Motley Fool

Earnings Scheduled For February 26, 2024 ↗

February 26, 2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.

Via Benzinga

BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth ↗

May 03, 2023

Via Benzinga

Recap: BioCryst Pharma Q1 Earnings ↗

May 03, 2023

Via Benzinga

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

BCRX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗

September 18, 2023

Via Benzinga

3 Magnificent Growth Stocks to Buy on the Dip ↗

August 28, 2023

These three biotech stocks are attractive buys right now.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗

August 04, 2023

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript ↗

August 03, 2023

BCRX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023 ↗

July 13, 2023

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript ↗

May 03, 2023

BCRX earnings call for the period ending March 31, 2023.

Via The Motley Fool

Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today? ↗

April 18, 2023

BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts.

Via InvestorPlace

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.